Wilson Sonsini Goodrich & Rosati represented Cleveland Diagnostics on the transaction. Cleveland Diagnostics, a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Voluware on the deal. Voluware, an award-winning provider of solutions to speed and simplify prior authorizations, announced a capital investment...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Trutino Biosciences on the deal. Boehringer Ingelheim, a leading research-driven biopharmaceutical company, announced the signing of an option to acquire...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised Riverstone Holdings LLC on the deal while Wilson Sonsini represented Infinitum Electric. Riverstone Holdings LLC acted as lead investor in Infinitum Electric’s...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SR One on the deal. Simcha Therapeutics, a biotechnology company developing cytokine-based cancer immunotherapies, announced the closing of a $40...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Logos Capital on the deal while Sidley represented Attralus, Inc. Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines...
You must be a Standard 1 Year member to access this content.
